Shahin Merat - Dissemin

Language
Login

All papers authored by Shahin Merat

This paper was not found in any repository, but could be made available legally by the author.

2021 Anahita Sadeghi

ORCID

, Roya Amiri, Elham Akbarpour, Babak Mirminachi, Amir‐Houshang Sharifi, Shahin Merat

ORCID

Changes in liver fibrosis in patients with chronic hepatitis C after successful direct‐acting antiviral therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Fatemeh Roozbeh, Majid Saeedi, Reza Alizadeh-Navaei, Akbar Hedayatizadeh-Omran, Shahin Merat

ORCID

, Hannah Wentzel, Jacob Levi, Andrew Hill, Amir Shamshirian

ORCID

Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Bryony Simmons, Hannah Wentzel, Sara Mobarak, Gholamali Eslami, Anahita Sadeghi

ORCID

, Ali Ali Asgari, Hamideh Abbaspour Kasgari, Hafez Tirgar Fakheri, Shahin Merat

ORCID

, Andrew Hill

Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis

Upload

This paper was not found in any repository, but could be made available legally by the author.

Hamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani

ORCID

, Farhang Babamahmoodi, Ali Reza Davoudi Badabi, Lotfollah Davoudi, Ahmad Alikhani, Akbar Hedayatizadeh Omran, Majid Saeedi, Shahin Merat

ORCID

, Hannah Wentzel, Anna Garratt, Jacob Levi, Bryony Simmons, Andrew Hill and 1 other authors

Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Anahita Sadeghi

ORCID

, Ali Ali Asgari, Alireza Norouzi, Zahedin Kheiri, Amir Anushirvani, Mahnaz Montazeri, Hadiseh Hosamirudsai, Shirin Afhami, Elham Akbarpour

ORCID

, Rasoul Aliannejad, Amir Reza Radmard, Amir H. Davarpanah, Jacob Levi, Hannah Wentzel, Ambar Qavi and 4 other authors

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Hossein Poustchi

ORCID

, Sara Majd Jabbari, Shahin Merat

ORCID

, Amir‐Houshang Sharifi, Ali Akbar Shayesteh, Elahe Shayesteh, Mohammad Minakari, Mohammad Reza Fattahi, Maryam Moini, Fatemeh Roozbeh, Fariborz Mansour‐Ghanaei, Behrooz Afshar, Marjan Mokhtare, Taghi Amiriani, Masoomeh Sofian and 11 other authors

The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment

Upload

Missing publications? Search for publications with a matching author name.